{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:38Z","timestamp":1772165618447,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Schistosoma mansoni<\/jats:italic>\n                      related hepatic fibrosis is usually associated with hemodynamic alteration with increased mortality due to bleeding varices. The diagnosis of varices before bleeding imposes a big challenge in resource-limited countries using endoscopy. Published evidence on the utility of non-invasive clinical tools in predicting the presence of varices among patients with\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      related periportal fibrosis is still inadequate including Aspartate to platelet ratio index (APRI) and Platelet to splenic diameter ratio (PSDR) levels. This study describes the determinants of portal varices and assesses the potential utility of the APRI and PSDR level in the discrimination of portal varices among patients with\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      related periportal fibrosis (PPF).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A case\u2013control study using cross-sectional data was done among patients with\n                      <jats:italic>Schistosoma mansoni<\/jats:italic>\n                      related periportal fibrosis at Bugando Medical Centre, in Mwanza Tanzania. The derivation cohort included patients enrolled between 2015 and 2019 and the validation cohort included patients enrolled from 2019 till March 2021. Socio-demographic, laboratory, ultrasound, and upper digestive endoscopic information were analyzed using STATA 13. The prevalence and determinants of varices were determined by logistic regression. The sensitivity and specificity of independent factors were determined to assess their utility in discriminating the presence of portal varices in patients with PPF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 250 patients were included in the derivation cohort, 109 (43.6%; 95% CI 37.3\u201349.9) of them had varices. The odds of having varices were independently increased among patients with higher APRI levels than 1.51, (AOR: 5.8; 95% CI 3.1\u201311.1;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and PSDR levels that were lower than 5700 (AOR: 5.9; 95% CI 3.2\u201311.2;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Both APRI and PSDR levels had significantly high sensitivity and specificity in predicting the presence of esophageal varices. However, the combined values of APRI and PSDR had higher specificity than any of the two markers. Of the 200 patients in the validation cohort 94 (47.0%; 95% CI 40.0\u201354.2) had varices, the discriminative power of the final model and the predictive ability of both APRI, PSDR, and APRI-PSDR combined levels were highly maintained.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study indicates that varices are a common encounter among patients with\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      related periportal fibrosis and it is independently associated with higher APRI and lower PSDR levels suggesting that these tools are potential discriminators of varices in this subgroup of patients. The reproducibility of these results should further be assessed longitudinally as potential non-invasive tools in selecting patients at high risk of having esophageal varices who could benefit from the targeted endoscopic intervention in a resource-limited setting like ours.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-01802-9","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T06:03:01Z","timestamp":1620885781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Schistosoma mansoni-related periportal fibrosis; can we use APRI and PSDR levels in the real-time selection of patients for targeted endoscopy in a resource-limited setting? A case\u2013control study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-9321","authenticated-orcid":false,"given":"Daniel W.","family":"Gunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth F.","family":"Mtui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina M.","family":"Manyiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Majinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semvua B.","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humphrey D.","family":"Mazigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson R.","family":"Kidenya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"issue":"2","key":"1802_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bjid.2014.11.004","volume":"19","author":"AF Adenowo","year":"2015","unstructured":"Adenowo AF, et al. Impact of human schistosomiasis in sub-Saharan Africa. Braz J Infect Diseases. 2015;19(2):196\u2013205.","journal-title":"Braz J Infect Diseases"},{"key":"1802_CR2","doi-asserted-by":"crossref","unstructured":"Hotez, P.J., O.A. Asojo, and A.M. Adesina, Nigeria: \"Ground Zero\" for the High Prevalence Neglected Tropical Diseases. 2012, Public Library of Science.","DOI":"10.1371\/journal.pntd.0001600"},{"key":"1802_CR3","unstructured":"WHO, Schistosomiasis: Progress report 2001\u20132011 and Strategic plan 2012\u20132020. 2013: p. 74."},{"key":"1802_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.11604\/pamj.2016.24.296.9755","volume":"24","author":"CK Opio","year":"2016","unstructured":"Opio CK, et al. Profiling lifetime episodes of upper gastrointestinal bleeding among patients from rural Sub-Saharan Africa where Schistosoma mansoni is endemic. Pan Afr Med J. 2016;24:296.","journal-title":"Pan Afr Med J"},{"key":"1802_CR5","doi-asserted-by":"publisher","first-page":"d2651","DOI":"10.1136\/bmj.d2651","volume":"342","author":"DJ Gray","year":"2011","unstructured":"Gray DJ, et al. Diagnosis and management of schistosomiasis. BMJ. 2011;342:d2651.","journal-title":"BMJ"},{"issue":"5","key":"1802_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3347\/kjp.2015.53.5.545","volume":"53","author":"GM Kaatano","year":"2015","unstructured":"Kaatano GM, et al. Schistosoma mansoni-related hepatosplenic morbidity in adult population on Kome Island, Sengerema district, Tanzania. Korean J Parasitol. 2015;53(5):545.","journal-title":"Korean J Parasitol"},{"issue":"1","key":"1802_CR7","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12879-019-4451-z","volume":"19","author":"A Mueller","year":"2019","unstructured":"Mueller A, et al. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities, and their associated factors. BMC Infect Dis. 2019;19(1):832.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1802_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/1319-3767.84483","volume":"17","author":"A Agha","year":"2011","unstructured":"Agha A, et al. Use of the platelet count\/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol. 2011;17(5):307\u201311.","journal-title":"Saudi J Gastroenterol"},{"issue":"2","key":"1802_CR9","first-page":"164","volume":"97","author":"S Bessa","year":"1985","unstructured":"Bessa S, Helmy I. Injection sclerotherapy for esophageal varices caused by schistosomal hepatic fibrosis. Surgery. 1985;97(2):164\u20138.","journal-title":"Surgery"},{"issue":"4","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0016-5107(88)71363-2","volume":"34","author":"A El-Zayadi","year":"1988","unstructured":"El-Zayadi A, El-Din SS, Kabil S. Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointest Endosc. 1988;34(4):314\u20137.","journal-title":"Gastrointest Endosc"},{"key":"1802_CR11","first-page":"1","volume":"2014","author":"D LaBrecque","year":"2014","unstructured":"LaBrecque D, et al. Esophageal varices. World Gastroenterol Organ Glob Guidel. 2014;2014:1\u201314.","journal-title":"World Gastroenterol Organ Glob Guidel"},{"issue":"2","key":"1802_CR12","first-page":"28","volume":"2","author":"MA Hassan","year":"2018","unstructured":"Hassan MA, et al. Noninvasive prediction of esophageal varices grade (size) in sudanese patients with periportal fibrosis. Gastroenterology. 2018;2(2):28\u201333.","journal-title":"Gastroenterology"},{"issue":"5","key":"1802_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/1319-3767.84483","volume":"17","author":"A Agha","year":"2011","unstructured":"Agha A, et al. Use of the platelet count\/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol: Off J Saudi Gastroenterol Assoc. 2011;17(5):307.","journal-title":"Saudi J Gastroenterol: Off J Saudi Gastroenterol Assoc"},{"issue":"9","key":"1802_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1365-3156.1998.00285.x","volume":"3","author":"J Richter","year":"1998","unstructured":"Richter J, et al. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Trop Med Int Health. 1998;3(9):728\u201335.","journal-title":"Trop Med Int Health"},{"key":"1802_CR15","unstructured":"Abdel-Wahab MF, et al. Ultrasonographic prediction of esophageal varices in Schistosomiasis mansoni. Am J Gastroenterol. 1993;88(4)."},{"issue":"46","key":"1802_CR16","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.3748\/wjg.v21.i46.13132","volume":"21","author":"M Derbala","year":"2015","unstructured":"Derbala M, et al. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection. World J Gastroenterol. 2015;21(46):13132.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1802_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1590\/s0004-2803.2017v54n1-10","volume":"54","author":"AVMS Barreto","year":"2017","unstructured":"Barreto AVMS, et al. New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni. Arq Gastroenterol. 2017;54(1):51\u20136.","journal-title":"Arq Gastroenterol"},{"key":"1802_CR18","first-page":"1","volume":"2017","author":"R Chen","year":"2017","unstructured":"Chen R, et al. Platelet count to spleen diameter ratio for the diagnosis of gastroesophageal varices in liver cirrhosis: a systematic review and meta-analysis. Gastroenterol Res Pract. 2017;2017:1.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"1802_CR19","first-page":"42","volume":"28","author":"H Mudawi","year":"2008","unstructured":"Mudawi H, Ali Y, El Tahir M. Prevalence of gastric varices and portal hypertensive gastropathy in patients with Symmers periportal fibrosis. Ann Saudi Med. 2008;28(1):42\u20134.","journal-title":"Ann Saudi Med"},{"key":"1802_CR20","volume-title":"Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity: Second international workshop, October 22\u201326 1996, Niamey, Niger","author":"J Richter","year":"2000","unstructured":"Richter J, et al. Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity: Second international workshop, October 22\u201326 1996, Niamey, Niger. Geneva: World Health Organization; 2000."},{"issue":"11","key":"1802_CR21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013;158(11):807\u201320.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1802_CR22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.52.8.1200","volume":"52","author":"E Giannini","year":"2003","unstructured":"Giannini E, et al. Platelet count\/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52(8):1200\u20135.","journal-title":"Gut"},{"issue":"3\u20134","key":"1802_CR23","first-page":"395","volume":"72","author":"MA Madwar","year":"1997","unstructured":"Madwar MA, et al. A prospective study: prediction of the first variceal hemorrhage in schistosomal and non-schistosomal liver disease. J Egypt Public Health Assoc. 1997;72(3\u20134):395\u2013409.","journal-title":"J Egypt Public Health Assoc"},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2334-14-303","volume":"14","author":"AA Chofle","year":"2014","unstructured":"Chofle AA, et al. Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort study. BMC Infect Dis. 2014;14:303.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1802_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MEG.0000000000000584","volume":"28","author":"X-D Xu","year":"2016","unstructured":"Xu X-D, et al. Ratio of platelet count\/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28(5):588\u201391.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"1802_CR26","first-page":"447","volume":"12","author":"MW Fagerland","year":"2012","unstructured":"Fagerland MW, Hosmer DW. A generalized Hosmer-Lemeshow goodness-of-fit test for multinomial logistic regression models. Stand Genomic Sci. 2012;12(3):447\u201353.","journal-title":"Stand Genomic Sci"},{"issue":"1","key":"1802_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29\u201336.","journal-title":"Radiology"},{"issue":"7","key":"1802_CR28","first-page":"693","volume":"8","author":"M Ravera","year":"1996","unstructured":"Ravera M, et al. Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda. Eur J Gastroenterol Hepatol. 1996;8(7):693\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5\u20136","key":"1802_CR29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.26719\/2000.6.5-6.926","volume":"6","author":"MM Kheir","year":"2000","unstructured":"Kheir MM, et al. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis. East Mediterr Health J. 2000;6(5\u20136):926\u201331.","journal-title":"East Mediterr Health J"},{"issue":"10","key":"1802_CR30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/bjs.1800781033","volume":"78","author":"AM Saad","year":"1991","unstructured":"Saad AM, et al. Oesophageal varices in a region of Sudan endemic for Schistosoma mansoni. Br J Surg. 1991;78(10):1252\u20133.","journal-title":"Br J Surg"},{"issue":"1","key":"1802_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2334-14-303","volume":"14","author":"AA Chofle","year":"2014","unstructured":"Chofle AA, et al. Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort study. BMC Infect Dis. 2014;14(1):303.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1802_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1258\/004947507781524719","volume":"37","author":"H Mudawi","year":"2007","unstructured":"Mudawi H, Ibrahim K. Endoscopic variceal sclerotherapy in patients with Symmers periportal fibroses. Trop Doct. 2007;37(3):179\u201381.","journal-title":"Trop Doct"},{"issue":"2","key":"1802_CR33","first-page":"28","volume":"2","author":"MA Hassan","year":"2018","unstructured":"Hassan MA, et al. Noninvasive prediction of esophageal varices grade (size) in Sudanese patients with periportal fibrosis. Int J Gastroenterol. 2018;2(2):28.","journal-title":"Int J Gastroenterol"},{"issue":"5","key":"1802_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1590\/S0037-86822007000500023","volume":"40","author":"JR Lambertucci","year":"2007","unstructured":"Lambertucci JR, dos Santos Silva LC, Antunes CM. Aspartate aminotransferase to platelet ratio index and blood platelet count are good markers for fibrosis evaluation in schistosomiasis mansoni. Rev Soc Bras Med Trop. 2007;40(5):599.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"7","key":"1802_CR35","doi-asserted-by":"publisher","first-page":"e2314","DOI":"10.1371\/journal.pntd.0002314","volume":"7","author":"LAC Leite","year":"2013","unstructured":"Leite LAC, et al. Hemostatic dysfunction is increased in patients with hepatosplenic Schistosomiasis mansoni and advanced periportal fibrosis. PLoS Neglect Trop Dis. 2013;7(7):e2314.","journal-title":"PLoS Neglect Trop Dis"},{"issue":"5","key":"1802_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5581\/1516-8484.20130098","volume":"35","author":"LAC Leite","year":"2013","unstructured":"Leite LAC, et al. Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis. Rev Bras Hematol Hemoter. 2013;35(5):332\u20136.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"1802_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1590\/S0004-28032014000100008","volume":"51","author":"TB Medeiros","year":"2014","unstructured":"Medeiros TB, et al. Correlation between platelet count and both liver fibrosis and spleen diameter in patients with Schistosomiasis mansoni. Arq Gastroenterol. 2014;51(1):34\u20138.","journal-title":"Arq Gastroenterol"},{"issue":"5","key":"1802_CR38","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1665-2681(19)31324-9","volume":"12","author":"\u00c2 Zambam de Mattos","year":"2013","unstructured":"Zambam de Mattos \u00c2, et al. Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices. Ann Hepatol. 2013;12(5):810\u20134.","journal-title":"Ann Hepatol"},{"key":"1802_CR39","first-page":"1","volume":"2018","author":"F Zhang","year":"2018","unstructured":"Zhang F, et al. Predictive value of a noninvasive serological hepatic fibrosis scoring system in cirrhosis combined with oesophageal varices. Can J Gastroenterol Hepatol. 2018;2018:1.","journal-title":"Can J Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01802-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T01:51:36Z","timestamp":1672105896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01802-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01802-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20359\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-20359\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-20359\/v3","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Catholic University of Health And Allied Sciences and Bugando Medical Centre joint ethical committee with an ethical clearance certificate number: 907\/2019, consent to participate not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of supporting data"}},{"value":"The authors declare to have no competing interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}